QuantHealth Raises $45M Series B for AI Trial Simulation
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- QuantHealth raised a $45M Series B round led by Qumra Capital, bringing its total funding to approximately $70M.
- QuantHealth, headquartered in Tel Aviv, provides AI-driven clinical trial simulation software used in drug development.
Why it matters: QuantHealth's $45M Series B, bringing total funding to ~$70M, signals continued investor appetite for AI tools that simulate clinical trials — a category pitched at cutting the cost and failure rate of drug development.
Ask SkimNews
